Inventor

George J. Todaro

Inventor

Seattle, WA, US

Overview

23→

Patents

1986–2001

Patent span

Human necessities

Primary field (CPC A)

Patents· 23 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

A61Kprimary

A61KPreparations for medical, dental or toiletry purposes31%

C07KPeptides24%

Y10STechnical subjects covered by former uspc cross-reference art collections [xracs] and digests17%

A61PSpecific therapeutic activity of chemical compounds or medicinal preparations10%

G01NInvestigating or analysing materials by determining their chemical or physical properties9%

C12NMicroorganisms or enzymes3%

A61LMethods or apparatus for sterilising materials or objects in general1%

C07CAcyclic or carbocyclic compounds1%

C07DHeterocyclic compounds1%

C12QMeasuring or testing processes involving enzymes, nucleic acids or microorganisms1%

PatentTitleYear

6,204,364'Hybrid cytokines'2001 6,171,824'Hybrid cytokines'2001 5,925,733'DNA polymerase of gamma herpes viruses associated with Kaposi\'s sarcoma and retroperitoneal fibromatosis'1999 5,786,349'Method for treating chlamydia infectious diseases by rifamycin derivative'1998 5,248,666'Methods for inhibiting neoplastic cell proliferation using platelet factor 4'1993 5,240,912'Transforming growth factor (TGF) peptides'1993 5,093,045'Biologically active lipids binding membrane receptors'1992 5,077,312'Biologically active lipids binding membrane receptors'1991 5,011,777'Vectors encoding brain derivable polypeptide factors'1991 4,990,289'Biologically active lipids binding membrane receptors'1991 4,963,485'Brain derivable polypeptide factors and antibodies thereto'1990 4,880,512'Pulsed light selective photolysis process for treatment of biological media and products made thereby'1989 4,863,899'Biologically active polypeptides'1989 4,816,442'Method of inhibiting tumor growth sensitive to CIF-.beta.treatment'1989 4,816,561'Biologically active polypeptides'1989 4,806,492'Polypeptide tumor inhibitors and antibodies thereto'1989 4,774,318'Snake venom growth arresting peptide'1988 4,737,580'Platelet related growth regulator'1988 4,731,439'Snake venom growth arresting peptide'1988 4,714,683'Polypeptide tumor inhibitors and antibodies thereto'1987 4,708,948'Substantially purified tumor growth inhibitory factor'1987 4,645,828'Platelet related growth regulator'1987 4,590,003'Platelet related growth regulator'1986

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

1986–1993Patents assigned to ONCOGEN (12)· patent assignee history

1986–2001Based in Seattle, WA, US· patent location history

1989–1993Patents assigned to TODARO GEORGE J (3)· patent assignee history

1989Patents assigned to COLLAGEN CORP (1)· patent assignee history

2001Patents assigned to FRED HUTCHINSON RES CT (1)· patent assignee history

2001Patents assigned to HUTCHINSON FRED CANCER RES (1)· patent assignee history

Inventor activity

Assignee and location history derived from the patent record.

Assignees

Assignee	Patents	Span
ONCOGEN	12	1986–1993
TODARO GEORGE Jself	3	1989–1993
COLLAGEN CORP	1	1989
FRED HUTCHINSON RES CT	1	2001
HUTCHINSON FRED CANCER RES	1	2001

Locations

Location	Patents	Span
Seattle, Washington, US	23	1986–2001